In addition, mRNA expression pattern of BIRC6 from the TCGA database was consistent with the above results from patient samples (Figure 12D), both indicating that NFYC-AS1 may promote tumor progress and act as a high-risk factor of poor prognosis in our constructed signature through the upregulation of BIRC6. This evidence concerns the gene NFYC and neoplasm.